Brief Summary

This study will evaluate healthy normal volunteers and patients with a variety of endocrine disorders to 1) learn more about conditions that affect the endocrine glands (glands that secrete hormones) and 2) train physicians in endocrinology. Patients with endocrine-related conditions and healthy volunteers of all ages may be eligible for this study. All participants will have a physical examination medical and history. They may be required to provide blood, saliva or urine samples and undergo ultrasound (using sound waves) or magnetic resonance (using a magnetic field) imaging to visualize internal body structures. Some healthy adult volunteers will have hormone-stimulating tests to assess endocrine function. These tests measure blood hormone levels before and after injection of a synthetic form of a hormone. A device called a heparin lock, through which the hormone is injected and the blood samples are collected, is placed in a vein in the arm or hand. Blood samples are drawn before the hormone is injected and at various intervals after the injection to measure levels of the hormone. These tests, which last from 1 to 3 hours, may include the following:

  1. 1.CRH stimulation test corticotropin-releasing hormone is given to test pituitary and adrenal gland function
  2. 2.ACTH stimulation test adrenocorticotrophic hormone is given to test adrenal gland function
  3. 3.LHRH stimulation test luteinizing hormone-releasing hormone is given to test pituitary gland function
  4. 4.TRH stimulation test thyroid-releasing hormone is given to test pituitary and thyroid gland function
  5. 5.GHRH stimulation test growth hormone releasing hormone is given to measure growth hormone levels.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,090

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2000

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 19, 2000

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

July 25, 2000

Completed
3 years until next milestone

First Posted

Study publicly available on registry

July 14, 2003

Completed
13.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2016

Completed
Last Updated

October 6, 2017

Status Verified

August 31, 2016

First QC Date

July 25, 2000

Last Update Submit

October 5, 2017

Conditions

Keywords

EvaluationEndocrinologyHormonesMetabolismTeachingEndocrine Disorder

Eligibility Criteria

AgeUp to 99 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy subjects and patients with endocrine-related conditions of all ages are eligible for this protocol. The actual selection of patients most appropriate for clinical training needs will be made by protocol investigators.
  • Subjects with disabilities are not formally excluded from the study unless the disability would specifically prevent their participation. If a subject with cognitive impairment wishes to participate, there must be available a family member or other qualified individual holding a durable power of attorney who is able to guide the impaired subject s participation and be an advocate for their interests. This participation is limited to the non-research, clinical training arm of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

Related Publications (1)

  • Han JC, Reyes-Capo DP, Liu CY, Reynolds JC, Turkbey E, Turkbey IB, Bryant J, Marshall JD, Naggert JK, Gahl WA, Yanovski JA, Gunay-Aygun M. Comprehensive Endocrine-Metabolic Evaluation of Patients With Alstrom Syndrome Compared With BMI-Matched Controls. J Clin Endocrinol Metab. 2018 Jul 1;103(7):2707-2719. doi: 10.1210/jc.2018-00496.

MeSH Terms

Conditions

Endocrine System Diseases

Study Officials

  • Margaret F Keil, C.R.N.P.

    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
OTHER
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2000

First Posted

July 14, 2003

Study Start

July 19, 2000

Study Completion

August 31, 2016

Last Updated

October 6, 2017

Record last verified: 2016-08-31

Locations